Literature DB >> 27836464

Apoptotic effect of atorvastatin in glioblastoma spheroids tumor cultured in fibrin gel.

Neda Bayat1, Somayeh Ebrahimi-Barough2, Abbas Norouzi-Javidan1, Hooshang Saberi1, Roksana Tajerian3, Mohammad Mehdi Mokhtari Ardakan3, Sadegh Shirian4, Arman Ai5, Jafar Ai6.   

Abstract

OBJECTIVE: Glioblastoma multiform (GBM) is one of the most common and highly aggressive primary brain tumors that thought to be of glial cells origin. The new available therapy for glioblastoma is based on better understanding of molecular malignant progression in this tumor. It is better to identify key molecular targets stimulating signaling pathways that lead to initiation of apoptosis for treatment of glioblastoma. Tumorigenesis broadly is controlled by tumor microenvironment and design of best biomimetic culture systems dependency on these conditions allow for in vitro and in vivo tumor modeling for studies of cancer cells behavior to drugs. We engineered three-dimensional (3D) human tumor models using U87 glioma cells in fibrin gel that mimic microenvironmental feature of glioblastoma in vivo. In this study, atorvastatin was used as a kind of statins for induction of apoptosis, and inhibition of migration and invasion in glioma cells.
METHODS: To reach for these aims, 3D model of glioma in fibrin gel was used with different concentrations of atorvastatin (1, 5, 10μM) to assay apoptotic genes expression by real time PCR and Tunel assay. After 24 and 48h exposing with different concentrations of atorvastatin, cell migration and invasion of tumor cells were investigated.
RESULTS: The results showed atorvastatin induced apoptosis of glioma spheroids dose- dependently. The most likely mechanisms are the induction of apoptosis by caspase-8- caspase-3 signaling pathway. The invasion and migration of U87 spheroid cells decreased after 48h especially with 10μM concentration of atorvastatin.
CONCLUSION: Finally these results suggest that this biomimetic model with fibrin may provide a vastly applicable 3D culture system to study the effect of anti-cancer drugs such as atrovastatin on tumor malignancy in vitro and in vivo and atorvastatin could be used as anticancer agent for glioblastoma treatment.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; Atorvastatin; Fibrin gel; Glioblastoma; Three dimensional culture

Mesh:

Substances:

Year:  2016        PMID: 27836464     DOI: 10.1016/j.biopha.2016.11.003

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  11 in total

1.  Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro.

Authors:  Hannah M Jones; Ziwei Fang; Wenchuan Sun; Leslie H Clark; Jessica E Stine; Arthur-Quan Tran; Stephanie A Sullivan; Timothy P Gilliam; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway.

Authors:  Jeng-Jer Shieh; Chun-Ying Wu; Sin-Ting Wang; Shi-Wei Huang; Kuang-Ting Liu; Teng-Yu Lee
Journal:  Cell Death Discov       Date:  2020-03-30

3.  Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature.

Authors:  Luis F Rendon; Ishaan A Tewarie; David J Cote; Aaron Gabriel; Timothy R Smith; Marike L D Broekman; Rania A Mekary
Journal:  Drugs       Date:  2022-02-05       Impact factor: 9.546

4.  Effects of three-dimensional collagen scaffolds on the expression profiles and biological functions of glioma cells.

Authors:  Wei Jia; Xingjun Jiang; Weidong Liu; Lei Wang; Bin Zhu; Hecheng Zhu; Xingdong Liu; Meizuo Zhong; Dan Xie; Wei Huang; Wenting Jia; Shasha Li; Xuxu Liu; Xiang Zuo; Damei Cheng; Jianwu Dai; Caiping Ren
Journal:  Int J Oncol       Date:  2018-03-20       Impact factor: 5.650

5.  Exosomes impact survival to radiation exposure in cell line models of nervous system cancer.

Authors:  Oliver D Mrowczynski; Achuthamangalam B Madhankumar; Jeffrey M Sundstrom; Yuanjun Zhao; Yuka Imamura Kawasawa; Becky Slagle-Webb; Christine Mau; Russell A Payne; Elias B Rizk; Brad E Zacharia; James R Connor
Journal:  Oncotarget       Date:  2018-11-16

6.  Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway.

Authors:  Jeng-Jer Shieh; Chun-Ying Wu; Sin-Ting Wang; Shi-Wei Huang; Kuang-Ting Liu; Teng-Yu Lee
Journal:  Cell Death Discov       Date:  2020-03-30

Review 7.  Droplet Microfluidics for Tumor Drug-Related Studies and Programmable Artificial Cells.

Authors:  Pantelitsa Dimitriou; Jin Li; Giusy Tornillo; Thomas McCloy; David Barrow
Journal:  Glob Chall       Date:  2021-05-07

8.  Clinical significance of pre-surgical serum lipid levels in patients with glioblastoma.

Authors:  Ruofei Liang; Junhong Li; Mao Li; Yuan Yang; Xiang Wang; Qing Mao; Yanhui Liu
Journal:  Oncotarget       Date:  2017-09-08

9.  Development of an in vitro cell-sheet cancer model for chemotherapeutic screening.

Authors:  Jaewang Lee; Daiha Shin; Jong-Lyel Roh
Journal:  Theranostics       Date:  2018-06-24       Impact factor: 11.556

10.  Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model.

Authors:  Arash Goodarzi; Mehdi Khanmohammadi; Arman Ai; Hamid Khodayari; Armin Ai; Morteza Sagharjoghi Farahani; Saeed Khodayari; Somayeh Ebrahimi-Barough; Sanam Mohandesnezhad; Jafar Ai
Journal:  Mol Biol Rep       Date:  2020-09-27       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.